Question explored with the scientific record
Conversation so far
- 1 Side effects of Fenisteride
- 2 And tAMSULOSIN
Answered on this page ↓
And tAMSULOSIN
The short version: tamsulosin has well-documented side effects including ejaculatory dysfunction, orthostatic hypotension, and a specific eye surgery complication, with the evidence showing these risks are real and dose-dependent.
The evidence here comes from a mix of manufacturer-funded and independent studies. The phase III trials [9, 10] that established tamsulosin's efficacy were funded by the manufacturer, a standard conflict that means the safety data in those trials should be read as a floor, not a ceiling. The crossover study on sperm parameters [3] was independent and gives a clearer picture of the sexual side effects.
The most striking finding is the ejaculatory dysfunction. In a randomized double-blind trial, 17 out of 48 healthy young men (about 35%) experienced anejaculation on tamsulosin 0.8 mg, compared to essentially zero on placebo [3]. Ejaculate volume dropped by an average of 2.4 mL, sperm count fell by 255 million, and motility decreased by 14% [3]. A meta-analysis comparing tamsulosin to the herbal alternative saw palmetto found that ejaculation disorders were about 12 times more likely with tamsulosin [11]. This is not a rare side effect. It is common and mechanistically linked to how the drug works on the seminal vesicles and vas deferens [5].
The cardiovascular effects are real but less dramatic. Tamsulosin blocks alpha-1 receptors in blood vessels, and higher doses measurably reduce the body's ability to constrict blood vessels in response to cold [4]. In elderly men, the risk of orthostatic hypotension (dizziness on standing) was about 11% in one study [3], though a comparison study suggested tamsulosin may cause less blood pressure drop than the older drug alfuzosin [2]. The interaction with the supplement quercetin, common in many diets, can amplify this effect [1].
The most surgically relevant side effect is intraoperative floppy iris syndrome (IFIS). In cataract surgery, patients on tamsulosin had a 48% rate of IFIS compared to 0.67% in controls [7]. The iris becomes floppy and billows during surgery, increasing complication risk. This happens because tamsulosin binds tightly to receptors in the iris dilator muscle and persists there [6, 8]. Even after stopping the drug, the risk remains for months because the drug binds to melanin in the eye and is released slowly [8].
| Side effect | Rate with tamsulosin | Rate with placebo/control | Source |
|---|---|---|---|
| Anejaculation | 35% (17/48) | ~0% | [3] |
| Orthostatic hypotension | 11% | 5% | [3] |
| IFIS during cataract surgery | 48% | 0.67% | [7] |
| Dizziness | 14% | 0% | [3] |
The evidence here covers short-term use (weeks to months). There are no long-term safety studies in the retrieval, and no studies on immune effects, viral reactivation, or colloidal stability. The known harms are concentrated in sexual function and surgical risk, and they are common enough that a patient should be told about them before starting the drug.
My call: tamsulosin causes frequent and clinically meaningful side effects, especially ejaculatory dysfunction and IFIS, that are well-documented in the evidence. The benefit for urinary symptoms must be weighed against these real risks. Confidence: high.
Sources used 11
-
The supplement–drug interaction of quercetin with tamsulosin on vasorelaxation
This study investigates the pharmacodynamic interaction between the dietary supplement quercetin and the drug tamsulosin, revealing that quercetin significantly enhances the vasorelaxation effects of tamsulosin, which may increase the risk of orthostatic hypotension in patients,…
DOI: 10.1016/j.ejphar.2014.11.006 -
Comparison of the Cardiovascular Effects of Tamsulosin Oral Controlled Absorption System (OCAS®) and Alfuzosin Prolonged Release (XL)
Two randomized, double-blind clinical pharmacology studies in healthy volunteers directly comparing cardiovascular effects of tamsulosin OCAS 0.4 mg with alfuzosin XL 10 mg show that tamsulosin OCAS produces consistently smaller cardiovascular effects and may have a greater safe…
DOI: 10.1016/j.eururo.2005.12.024 -
Effects of Alfuzosin and Tamsulosin on Sperm Parameters in Healthy Men: Results of a Short‐Term, Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study
In a short-term, randomized, double-blind, 3-way crossover study in 48 healthy men, tamsulosin reduced several semen parameters and caused aejaculation in many participants, whereas alfuzosin behaved similarly to placebo, suggesting drug-specific effects on ejaculation-related s…
DOI: 10.2164/jandrol.108.006874 -
Antagonistic activity of tamsulosin against human vascular α1-adrenergic receptors
This study investigates the vascular effects of tamsulosin hydrochloride, a selective α1A-adrenergic receptor antagonist, in healthy men, demonstrating that higher doses significantly reduce fingertip vasoconstrictor responses and increase the infusion rate of phenylephrine need…
DOI: 10.1067/mcp.2000.105354 -
Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men?
This mini-review evaluates how common medical treatments for benign prostatic hyperplasia (α-blockers and 5α-reductase inhibitors, alone or in combination) affect sexual function, summarizing risks of erectile and ejaculatory dysfunction as well as potential improvements from al…
DOI: 10.1016/s1879-5226(11)60003-1 -
Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles
This study compares the pharmacologic effects of alfuzosin and tamsulosin on isolated prostatic and iris dilator smooth muscles in rabbits, suggesting that alfuzosin may be less likely to cause intraoperative floppy-iris syndrome than tamsulosin.
DOI: 10.1016/j.jcrs.2007.10.045 -
Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin—a UK-based comparison of incidence and complication rates
This study investigates the incidence of intraoperative floppy iris syndrome (IFIS) and associated complications in patients undergoing cataract surgery while taking tamsulosin or doxazosin, revealing a significantly higher incidence and complication rate in those on tamsulosin.
DOI: 10.1007/s00417-013-2260-4 -
Effects of tamsulosin and silodosin on isolated albino and pigmented rabbit iris dilators: Possible mechanism of intraoperative floppy-iris syndrome
This study investigates the binding affinity of tamsulosin and silodosin to alpha-receptors and melanin pigment in isolated rabbit iris dilators to elucidate the mechanism behind intraoperative floppy-iris syndrome (IFIS).
DOI: 10.1016/j.jcrs.2012.05.025 -
A comparison of two phase III multicenter, placebo-controlled studies of tamsulosin in BPH
This study compares the efficacy and safety of two dosages of tamsulosin (0.4 mg and 0.8 mg) against placebo in men with benign prostatic hyperplasia over a 13-week period, demonstrating significant improvements in urinary symptoms and flow rates with minimal side effects.
DOI: 10.1007/BF02850012 -
Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial
This randomized, double-blind, phase 3 trial demonstrated that tamsulosin 0.4 mg is more effective than tamsulosin 0.2 mg and placebo in improving lower urinary tract symptoms in Asian patients with benign prostatic hyperplasia.
DOI: 10.1080/03007995.2018.1447451 -
Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
This study systematically reviews and meta-analyzes randomized controlled trials comparing Serenoa repens (saw palmetto) with tamsulosin for benign prostatic hyperplasia/LUTS, finding similar efficacy on IPSS, QoL, Qmax, PVR, and PSA with Serenoa repens improving prostate volume…
DOI: 10.1177/1557988320905407